Cargando…

Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases

The human T-lymphotropic viruses (HTLVs) are causative agents of severe diseases including adult T-cell leukemia. Similar to human immunodeficiency viruses (HIVs), the viral protease (PR) plays a crucial role in the viral life-cycle via the processing of the viral polyproteins. Thus, it is a potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kassay, Norbert, Mótyán, János András, Matúz, Krisztina, Golda, Mária, Tőzsér, József
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915765/ https://www.ncbi.nlm.nih.gov/pubmed/33562087 http://dx.doi.org/10.3390/life11020127

Ejemplares similares

Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
por: Mótyán, János András, et al.
Publicado: (2022)

Biochemical Characterization of Human Retroviral-Like Aspartic Protease 1 (ASPRV1)
por: Golda, Mária, et al.
Publicado: (2020)

Biochemical characterization of Ty1 retrotransposon protease
por: Gazda, Lívia Diána, et al.
Publicado: (2020)

Functional Study of the Retrotransposon-Derived Human PEG10 Protease
por: Golda, Mária, et al.
Publicado: (2020)

Comparative virology of HTLV-1 and HTLV-2
por: Martinez, Michael P., et al.
Publicado: (2019)

Fine tuning of the temporal expression of HTLV-1 and HTLV-2
por: Cavallari, Ilaria, et al.
Publicado: (2013)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

The discovery of the first human retrovirus: HTLV-1 and HTLV-2
por: Gallo, Robert C
Publicado: (2005)

Subtype Analysis of HTLV‐1 in Patients with HTLV‐1 Uveitis
por: Ono, Ayako, et al.
Publicado: (1994)

Vertical Transmission of HTLV‐1 in HTLV‐1 Carrier Rat
por: Ami, Yoshihiro, et al.
Publicado: (1992)

Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease
por: Miczi, Márió, et al.
Publicado: (2020)

Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
por: Abdelbary, Nashwa H, et al.
Publicado: (2011)

Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain
por: Treviño, Ana, et al.
Publicado: (2011)

Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain
por: Treviño, Ana, et al.
Publicado: (2012)

HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties
por: Ciminale, Vincenzo, et al.
Publicado: (2014)

ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
por: Cachat, Anne, et al.
Publicado: (2014)

HTLV-3/STLV-3 and HTLV-4 Viruses: Discovery, Epidemiology, Serology and Molecular Aspects
por: Mahieux, Renaud, et al.
Publicado: (2011)

HTLV-1 uveitis
por: Kamoi, Koju, et al.
Publicado: (2012)

HTLV-1 in Ophthalmology
por: Kamoi, Koju
Publicado: (2020)

HTLV-1 Disease
por: Journo, Chloé, et al.
Publicado: (2021)

Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System
por: Mahdi, Mohamed, et al.
Publicado: (2015)

Development of HTLV-1 Database for data management and datamining HTLV-1 sequences
por: Araujo, Thessika H A, et al.
Publicado: (2011)

Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis
por: Barbeau, Benoit, et al.
Publicado: (2013)

HTLV‐I Uveitis: A Distinct Clinical Entity Caused by HTLV‐I
por: Mochizuki, Manabu, et al.
Publicado: (1992)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2
por: Lin, Edward, et al.
Publicado: (2022)

Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2
por: Rende, Francesca, et al.
Publicado: (2012)

Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
por: Mótyán, János András, et al.
Publicado: (2022)

HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection
por: Bangham, Charles R.M., et al.
Publicado: (2014)

Functional comparison of the HTLV-1 and HTLV-2 antisense viral proteins: implications for pathogenesis
por: Panfil, Amanda R, et al.
Publicado: (2015)

Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors
por: Harrod, Robert
Publicado: (2019)

Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection
por: Araujo, Abelardo Q.-C.
Publicado: (2020)

Reflections on Some of the Exceptional Features of HTLV-1 and HTLV-1 Research: A Perspective
por: Gallo, Robert C., et al.
Publicado: (2022)

HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil
por: Nunes, David, et al.
Publicado: (2017)

Specificity of the HIV-1 Protease on Substrates Representing the Cleavage Site in the Proximal Zinc-Finger of HIV-1 Nucleocapsid Protein
por: Mótyán, János András, et al.
Publicado: (2021)

Expression of the HBZ and tax genes of HTLV-1in infective dermatitis associated with HTLV-I (IDH)
por: Batista, Everton S, et al.
Publicado: (2011)

Seroprevalence of HTLV‐1 and HTLV‐2 amongst mothers and children in Malawi within the context of a systematic review and meta‐analysis of HTLV seroprevalence in Africa
por: Fox, James M., et al.
Publicado: (2016)

The HTLV-1 Tax interactome
por: Boxus, Mathieu, et al.
Publicado: (2008)

HTLV-1 and Innate Immunity
por: Journo, Chloé, et al.
Publicado: (2011)

The HTLV-1 Virological Synapse
por: Nejmeddine, Mohamed, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ip9olrcpnnrdcq2ff28r5r00h7